The Research Participant Advocate is a trained specialist who is a resource for study volunteers and a liaison to investigators, study teams, and staff. Patricia will be assisting participants and members of the Tufts research community and committed to protecting the safety and confidentiality of research participants. She received her Doctorate of Nursing Practice Degree … Continued
Dr. Beninger joins Tufts CTSI as Associate Director of Regulatory Affairs. He is Associate Professor of Public Health & Community Medicine at Tufts University School of Medicine, where he is the Director of the MD/MBA and MBS/MBA Programs. He has more than three decades of experience as a regulator and member of the Senior Executive … Continued
Ms. Kurtz-Rossi’s research interests include behavioral science and health communication, including: integrating health literacy and cultural humility training into global health workforce development to eliminate health disparities; creating audience-centered health communication using plain language principles to enhance understanding and facilitate action; working with hospitals and health centers to implement the 10 attributes of a health- … Continued
Dr. Trinquart is the Director of the Center for Clinical Trials at the Institute for Clinical Research and Health Policy Studies and Tufts CTSI. He also is the Director of the Data and Safety Monitoring Board program. He is an Associate Professor in the Department of Medicine at Tufts University School of Medicine, and adjunct … Continued
In addition to his role at Tufts CTSI, Andreas Klein served as Chair of the Tufts Health Sciences Campus Institutional Review Board (IRB) from 2010 through 2019. Dr. Klein is an attending physician and Associate Chief in the Division of Hematology/Oncology at Tufts Medical Center. He is the Director of the Transplant and Cellular Therapy … Continued
Dr. Davis is Vice-Chair of Pediatrics and Chief of Newborn Medicine at Tufts Medical Center and Professor of Pediatrics at Tufts University School of Medicine. His research has focused on neonatal drug development, including optimizing approaches to treat neonatal abstinence syndrome. He is currently funded by NIH and FDA to develop better biomarkers and outcome … Continued